These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9301503)

  • 21. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus.
    Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ
    Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetyltransferase 2 gene polymorphism and presbycusis.
    Unal M; Tamer L; Doğruer ZN; Yildirim H; Vayisoğlu Y; Camdeviren H
    Laryngoscope; 2005 Dec; 115(12):2238-41. PubMed ID: 16369173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-acetyltransferase (NAT2) polymorphism and breast cancer susceptibility: a lack of association in a case-control study of Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Int J Toxicol; 2004; 23(1):25-31. PubMed ID: 15162844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
    Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
    Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma.
    Ladero JM; Agúndez JA; Olivera M; Lozano L; Rodríguez-Lescure A; Diaz-Rubio M; Benítez J
    Eur J Clin Pharmacol; 2002 May; 58(2):115-8. PubMed ID: 12012143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of N-acetyltransferase activity: should caffeine phenotyping and NAT2 genotyping be used interchangeably in epidemiological studies?
    Le Marchand L; Sivaraman L; Franke AA; Custer LJ; Wilkens LR; Lau AF; Cooney RV
    Cancer Epidemiol Biomarkers Prev; 1996 Jun; 5(6):449-55. PubMed ID: 8781741
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
    Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
    Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A slow acetylator genotype associated with an increased risk of advanced cervical cancer.
    Costa S; Medeiros R; Vasconcelos A; Pinto D; Lopes C
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):678-82. PubMed ID: 12474054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease.
    van der Walt JM; Martin ER; Scott WK; Zhang F; Nance MA; Watts RL; Hubble JP; Haines JL; Koller WC; Lyons K; Pahwa R; Stern MB; Colcher A; Hiner BC; Jankovic J; Ondo WG; Allen FH; Goetz CG; Small GW; Mastaglia F; Roses AD; Stajich JM; Booze MW; Fujiwara K; Gibson RA; Middleton LT; Scott BL; Pericak-Vance MA; Vance JM
    Neurology; 2003 Apr; 60(7):1189-91. PubMed ID: 12682333
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acetylation genotype and phenotype in patients with systemic lupus erythematosus.
    Rychlik-Sych M; Skretkowicz J; Gawrońska-Szklarz B; Górnik W; Sysa-Jedrzejowska A; Skretkowicz-Szarmach K
    Pharmacol Rep; 2006; 58(1):22-9. PubMed ID: 16531626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer.
    Bell DA; Stephens EA; Castranio T; Umbach DM; Watson M; Deakin M; Elder J; Hendrickse C; Duncan H; Strange RC
    Cancer Res; 1995 Aug; 55(16):3537-42. PubMed ID: 7627961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased genotype frequency of N-acetyltransferase 2 slow acetylation in patients with rheumatoid arthritis.
    Pawlik A; Ostanek L; Brzosko I; Gawroska-Szklarz B; Brzosko M; Dabrowska-Zamojcin E
    Clin Pharmacol Ther; 2002 Sep; 72(3):319-25. PubMed ID: 12235453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acetylation polymorphism and prevalence of colorectal adenomas.
    Probst-Hensch NM; Haile RW; Ingles SA; Longnecker MP; Han CY; Lin BK; Lee DB; Sakamoto GT; Frankl HD; Lee ER
    Cancer Res; 1995 May; 55(10):2017-20. PubMed ID: 7743494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acetylator status and N-acetyltransferase 2 gene polymorphisms; phenotype-genotype correlation with the sulfamethazine test.
    Taja-Chayeb L; González-Fierro A; Miguez-Muñoz C; Trejo-Becerril C; Cruz-Hernandez Ede L; Cantu D; Agundez JA; Vidal-Millan S; Gutierrez O; Dueñas-González A
    Pharmacogenet Genomics; 2011 Dec; 21(12):894-901. PubMed ID: 21946899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.
    Ozawa S; Katoh T; Inatomi H; Imai H; Kuroda Y; Ichiba M; Ohno Y
    Int J Cancer; 2002 Dec; 102(4):418-21. PubMed ID: 12402313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Studies on N-Acetyltransferase (NAT2) Genotype Relationships in Emiratis: Confirmation of the Existence of Phenotype Variation among Slow Acetylators.
    Al-Ahmad MM; Amir N; Dhanasekaran S; John A; Abdulrazzaq YM; Ali BR; Bastaki S
    Ann Hum Genet; 2017 Sep; 81(5):190-196. PubMed ID: 28653770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cloning, expression, and functional characterization of two mutant (NAT2(191) and NAT2(341/803)) and wild-type human polymorphic N-acetyltransferase (NAT2) alleles.
    Ferguson RJ; Doll MA; Rustan TD; Gray K; Hein DW
    Drug Metab Dispos; 1994; 22(3):371-6. PubMed ID: 7915226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
    Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
    DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative analysis of N-acetylation polymorphism in humans as determined by phenotyping and genotyping].
    Goldenkova-Pavlova IV; Bruskin SA; Abdeev RM; Markarova EV; Bigvava SG; Radkevich LA; Kozhekbaeva ZhM; Glotov AS; Gra OA; Zasedatelev AS; Nasedkina TV; Kurdanov KhA; Piruzian ES
    Genetika; 2006 Aug; 42(8):1143-50. PubMed ID: 17025166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of NAT2 in relation to sulphasalazine-induced agranulocytosis.
    Wadelius M; Stjernberg E; Wiholm BE; Rane A
    Pharmacogenetics; 2000 Feb; 10(1):35-41. PubMed ID: 10739170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.